John Mwangi | Cervical Cancer | Best Researcher Award

Mr. John Mwangi | Cervical Cancer | Best Researcher Award

Student at University of Kwazulu Natal | Kenya

Mr. John Hiuhu Mwangi is a distinguished scholar and lecturer specializing in Community Health Nursing, Public Health, and Monitoring and Evaluation. Currently serving at Kirinyaga University, he is pursuing a PhD in Nursing and Public Health at the University of KwaZulu-Natal. His research expertise spans reproductive health, cervical cancer prevention, male partner involvement in healthcare, and socio-cultural determinants influencing health service uptake in low-resource settings. Mr. Mwangi has authored and co-authored several peer-reviewed publications in reputable journals such as Global Journal of Health Sciences, The East and Central Africa Medical Journal, Biomedical Sciences, Journal of Health, Medicine and Nursing, Health SA Gesondheid, and PLOS ONE. His notable works explore cervical cancer screening utilization, syndromic management of sexually transmitted infections, contraceptive uptake, and men’s roles in cervical cancer prevention. A strong advocate for evidence-based health interventions, he has presented his research at national and international conferences addressing reproductive health, community engagement, and public health innovation. His scholarly efforts have significantly contributed to advancing gender-inclusive health practices and strengthening health systems in sub-Saharan Africa. According to citation metrics, Dr. Mwangi has been cited 13 times (12 since 2020), with an h-index of 2, reflecting his growing impact and ongoing contribution to nursing and public health research.

Profile: Orcid | Google Scholar

Featured Publications

  1. Mwangi, J. H. (2015). Utilization of the visual inspection screening method for cancer of the cervix in Kitui Central Sub County, Kenya [Doctoral dissertation, Kenyatta University].

  2. Mwangi, J. H., Mtshali, G. N., & Mbeje, P. N. (2025). Male partner roles in cervical cancer transmission and prevention in Central Kenya: A quantitative approach. Health SA Gesondheid, 30, 2858.

  3. Kamau, S., & Mwangi, J. (2021). Nurse related challenges faced by diploma level nurses before, during and after upgrading to baccalaureate level at a level 5 hospital. Global Journal of Health Sciences.

  4. Mumbi, M. E., Hiuhu, M. J., Tharao, N. F., & Nyambura, M. N. (2020). Knowledge of nurses on syndromic management of sexually transmitted infections in public facilities. Journal of Health, Medicine and Nursing, 5(5), 1–12.

  5. Mwangi, J. H., & Gachau, A. G. (2017). The levels of utilization of visual inspection screening of cervical cancer in Kitui, Kenya. The East and Central Africa Medical Journal, 4(3), 30–34.

 

Ding Qi | Precancerous Cervical Lesions | Best Researcher Award

Mrs. Ding Qi | Precancerous Cervical Lesions | Best Researcher Award

Physician at The Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, China

Ding Qi is a dedicated physician with extensive experience in natural medicine research. Currently working at The Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, her primary focus is on developing innovative natural treatments to block the progression of cervical precancerous lesions and improve the outcomes for female reproductive system cancers. With a strong background in oncology, Dr. Qi is committed to enhancing patient quality of life through natural therapies. Her pioneering work includes developing a new natural preparation for cervical precancerous lesions.

Publication Profile : 

Scopus

Orcid

Educational Background 🎓

Ding Qi has completed rigorous academic training in the medical field, obtaining a degree in medicine from a prestigious institution. Throughout their academic journey, they have specialized in fields related to traditional Chinese medicine and oncology, developing a deep understanding of medical research, clinical practices, and tumor-related treatments. This educational foundation has played a pivotal role in shaping their current focus on the development of new natural medicines for the treatment of female reproductive system tumors and precancerous lesions.

Professional Experience 💼

Ding Qi has extensive experience as a physician at The Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine. Over the years, Dr. Qi has focused on research into cervical precancerous lesions and their progression to cervical cancer, as well as the therapeutic potential of natural medicines in treating endometrial cancer. Their professional experience has also involved building animal models to study continuous cervical lesions, contributing to the field of reproductive system tumors. Dr. Qi’s work is deeply committed to advancing medical research and improving patient outcomes through innovative, natural therapeutic approaches.

Research Interests 🔬

Qi’s research is focused on tumors of the female reproductive system, particularly how natural medicines can prevent the progression of precancerous lesions. Her recent work is centered around the therapeutic effects of natural medicines on endometrial cancer, and she is also developing an animal model for spontaneous cervical lesions. Her ultimate goal is to develop new treatments that improve patient outcomes and quality of life in the field of gynecological oncology.

Achievements 🌟

  • Ongoing Research: The therapeutic effect of natural medicines on endometrial cancer.
  • Patents: Animal model construction for spontaneous cervical continuous lesions.
  • Innovation: Developed a natural preparation to treat precancerous lesions of the cervix.

Publications 📚

  • Han, B., Yuan, M., Gong, Y., Sun, Y., & Liu, L. (2023). The clinical course of untreated CIN2 (HPV16/18+) under active monitoring: A protocol of systematic reviews and meta-analysis. Medicine (United States), 102(6), e32855. https://doi.org/[DOI]

  • Qi, D., Li, H., Wang, S., Han, B., & Liu, L. (2022). Construction of ceRNA network and key gene screening in cervical squamous intraepithelial lesions. Medicine (United States), 101(48), E31928. https://doi.org/[DOI]